| Income Statement |
| Total Revenue | 12.40K |
|
| Revenues (USD) | 12.40K |
| Cost of Revenue | 6.64K |
| Gross Profit | 5.76K |
| Operating Expenses | 3.04M |
| Research and Development Expense | 394.77K |
| Selling, General and Administrative Expense | 2.47M |
| Operating Income | -3.03M |
| Interest Expense | 743.94K |
| Net Income | -3.77M |
| Net Income Common Stock | -3.77M |
| Net Income Common Stock (USD) | -3.77M |
| Consolidated Income | -3.77M |
| Earnings per Basic Share | -2.68 |
| Earnings per Basic Share (USD) | -2.68 |
| Earnings per Diluted Share | -2.68 |
| Earning Before Interest & Taxes (EBIT) | -3.03M |
| Earning Before Interest & Taxes (USD) | -3.03M |
| Weighted Average Shares | 1.41M |
| Weighted Average Shares Diluted | 1.41M |
| Balance Sheet |
| Cash and Equivalents | 456.07K |
| Cash and Equivalents (USD) | 456.07K |
| Trade and Non-Trade Receivables | 32.69K |
| Current Assets | 3.58M |
| Property, Plant & Equipment Net | 1.23M |
| Total Assets | 7.51M |
| Debt Current | 1.84M |
| Total Debt | 2.35M |
| Current Liabilities | 13.05M |
| Debt Non-Current | 500.91K |
| Total Liabilities | 13.55M |
| Accumulated Retained Earnings (Deficit) | -69.69M |
| Shareholders Equity | -6.05M |
| Shareholders Equity (USD) | -6.05M |
| Assets Non-Current | 3.93M |
| Total Debt (USD) | 2.35M |
| Deferred Revenue | 1.98M |
| Goodwill and Intangible Assets | 2.67M |
| Inventory | 2.67M |
| Liabilities Non-Current | 500.91K |
| Trade and Non-Trade Payables | 6.62M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 202.82K |
| Net Cash Flow from Financing | 1.44M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -397.66K |
| Capital Expenditure | -39.30K |
| Issuance (Purchase) of Equity Shares | 819.59K |
| Issuance (Repayment) of Debt Securities | 622.59K |
| Net Cash Flow from Investing | -39.30K |
| Net Cash Flow from Operations | -1.80M |
| Share Based Compensation | 1.61K |